Efficacy and Safety of Balloon Guide Catheter in Mechanical Thrombectomy Patients

NCT ID: NCT03754738

Last Updated: 2018-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

155 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-25

Study Completion Date

2020-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

With mechanical thrombectomy now representing standard of care for treatment of acute ischemic stroke secondary to large vessel occlusion, identifying adjunctive techniques that result in improved outcomes for patients with LVO has become an issue of increasing importance. A number of retrospective studies have demonstrated that flow arrest during the clot retrieval process results in less clot fragmentation, lower rates of distal emboli, higher revascularization rates and improved rates of good neurological outcome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mechanical Thrombectomy Stroke Balloon Guide Catheter

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Balloon guide catheter group

mechanical thrombectomy with a balloon guide catheter group

Group Type EXPERIMENTAL

Balloon guide catheter

Intervention Type DEVICE

Use a balloon guide catheter in the mechanical thrombectomy

Non-balloon guide catheter group

mechanical thrombectomy with a non-balloon guide catheter group

Group Type ACTIVE_COMPARATOR

Non-balloon guide catheter

Intervention Type DEVICE

Use a non-balloon guide catheter in the mechanical thrombectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Balloon guide catheter

Use a balloon guide catheter in the mechanical thrombectomy

Intervention Type DEVICE

Non-balloon guide catheter

Use a non-balloon guide catheter in the mechanical thrombectomy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or older
* A clinical diagnosis of acute stroke, with a deficit on the NIHSS of 2 points or more.
* Intracranial arterial occlusion of the distal intracranial carotid artery or middle (M1/M2) or anterior (A1/A2) cerebral artery, demonstrated with CTA, MRA, or DSA.
* Treatment can be initiated (groin puncture) within 6 hours of symptom onset.
* Planning to mechanical thrombectomy with a stenting retriever.
* Signed informed consent prior to entering study.

Exclusion Criteria

* Moderate stenosis, severe stenosis, or occlusion of the ipsilateral extracranial carotid artery.
* Previously deployed stents in the ipsilateral carotid artery.
* Dissections of the ipsilateral carotid artery.
* Known hemorrhagic diathesis, coagulation factor deficiency, or oral anticoagulant therapy with INR \> 3.0.
* Baseline platelet count \< 50.000/µL.
* Baseline blood glucose of \< 50mg/dL or \>400mg/dl.
* Severe, sustained hypertension (SBP \> 220 mm Hg or DBP \> 110 mm Hg).
* Renal insufficiency with creatinine ≥ 3 mg/dl.
* Patients in sedation and intubated patients could not be included if baseline NIHSS is not obtained by a neurologist or emergency physician prior to sedation or intubation.
* Seizures at stroke onset which would preclude obtaining a baseline NIHSS.
* Unlikely to be available for 90 days follow-up (e.g. no fixed home address, visitor from overseas).
* Subject participating in a study involving an investigational drug or device that would impact this study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Capital Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ji Xunming,MD,PhD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Suzhou Municipal Hoapital

Suzhou, Anhui, China

Site Status NOT_YET_RECRUITING

Xuan Wu Hospital,Capital Medical University

Beijing, Beijing Municipality, China

Site Status RECRUITING

Lu He hospital, Capital Medical University

Beijing, Beijing Municipality, China

Site Status RECRUITING

Shengli Oilfield Central Hospital

Dongying, Shandong, China

Site Status NOT_YET_RECRUITING

Nanyang City Center Hospital

Nanyang, , China

Site Status RECRUITING

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, , China

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zhengfei Ma, MD

Role: primary

xunming ji

Role: primary

861013120136877

Xiaokun Geng, MD

Role: primary

18311055270

Zongen Gao

Role: primary

Changming Wen

Role: primary

13838729696

Yajun Lian

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Ma H, Che R, Zhang Q, Yu W, Wu L, Zhao W, Li M, Wu D, Wu C, Ji X. The optimum anticoagulation time after endovascular thrombectomy for atrial fibrillation-related large vessel occlusion stroke: a real-world study. J Neurol. 2023 Apr;270(4):2084-2095. doi: 10.1007/s00415-022-11515-y. Epub 2023 Jan 3.

Reference Type DERIVED
PMID: 36596867 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-ESCAPE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mechanical Thrombectomy Blood Flow Reversal
NCT06721338 TERMINATED PHASE1